Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.110
+0.040 (3.74%)
Mar 9, 2026, 3:31 PM EDT - Market open
Estrella Immunopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Selling, General & Admin | 3.94 | 3.14 | 3.2 | 0.66 | 0.3 | 0.28 |
| Research & Development | 9.56 | 5.72 | 4.11 | 10.45 | 1.39 | 0.46 |
| Operating Expenses | 13.51 | 8.85 | 7.31 | 11.11 | 1.69 | 0.73 |
| Operating Income | -13.51 | -8.85 | -7.31 | -11.11 | -1.69 | -0.73 |
| Pretax Income | -13.51 | -8.85 | -7.31 | -11.11 | -1.69 | -0.73 |
| Income Tax Expense | -0 | 0 | 0 | - | - | - |
| Net Income | -13.51 | -8.85 | -7.31 | -11.11 | -1.69 | -0.73 |
| Preferred Dividends & Other Adjustments | - | - | - | - | -0.61 | - |
| Net Income to Common | -13.51 | -8.85 | -7.31 | -11.11 | -1.07 | -0.73 |
| Shares Outstanding (Basic) | 37 | 37 | 27 | 0 | - | - |
| Shares Outstanding (Diluted) | 37 | 37 | 27 | 0 | - | - |
| Shares Change (YoY) | 2.36% | 34.73% | 8764.81% | - | - | - |
| EPS (Basic) | -0.37 | -0.24 | -0.27 | -36.35 | - | - |
| EPS (Diluted) | -0.37 | -0.24 | -0.27 | -36.35 | - | - |
| EBIT | -13.51 | -8.85 | -7.31 | -11.11 | -1.69 | -0.73 |
Source: S&P Capital IQ. Standard template.
Financial Sources.